Accessibility Menu
 

The Reason Why Endologix, Inc. Is Jumping 10% Today

The CE Mark of approval has been reinstated for the company's AFX and AFX2 endovascular AAA systems.

By Todd Campbell Updated Jan 25, 2017 at 4:33PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.